Related Experiment Video
Updated: Sep 10, 2025

A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
Caffeine Was Associated With Shorter Continuous Positive Airway Pressure Treatment for Infants up to Eight Weeks Old
Manon Casabianca1, David Akouka1, Linda Maman2
1Paediatric Emergency Department, Robert Debré University Hospital, Sorbonne University, Paris, France.
Insights
Caffeine administration in infants hospitalized for bronchiolitis significantly reduced the need for nutritional support and shortened the duration of respiratory support. This pilot study suggests caffeine may be a beneficial intervention for infants with bronchiolitis.
Area of Science:
- Pediatrics
- Neonatology
- Respiratory Medicine
Background:
- Bronchiolitis is a primary cause of infant hospitalization.
- Current treatment options for bronchiolitis are limited.
- Caffeine is known to stimulate respiratory function in infants.
Purpose of the Study:
- To investigate the impact of caffeine on infants hospitalized with bronchiolitis.
- To assess adverse events and the need for ventilatory and nutritional support.
Main Methods:
- Observational study conducted in two Paris hospitals.
- Recruited 186 infants up to 8 weeks old.
- Compared outcomes between infants who received caffeine and those who did not.
Main Results:
- Caffeine group required significantly less nutritional support (p < 0.001).
- Shorter duration of continuous positive airway pressure (CPAP) in the caffeine group (4.1 days vs. 7.1 days, p = 0.003).
- Caffeine was well tolerated with no significant adverse events reported.
Conclusions:
- Caffeine administration reduced CPAP duration and nutritional support needs in infants with bronchiolitis.
- Potential direct effect on the digestive system or overall improvement.
- Results warrant confirmation through randomized controlled trials.
Aim:
Bronchiolitis is the leading cause of hospitalisation before 1 year of age, with no treatment available, while caffeine stimulates respiratory function in young infants. This pilot study investigated the impact of caffeine on infants up to 8-week-old hospitalised for bronchiolitis, regardless of apnoea.
Method:
An observational study was conducted from October 2021 to February 2022 and from October 2022 to February 2023 in two Paris hospitals. The outcomes included adverse events and the need for, and duration of, ventilatory support and nutritional support.
Results:
We recruited 186 patients (55% boys) at a median age of 4.5 weeks. The 65 patients who received caffeine required nutritional support significantly less often than the no caffeine group (p < 0.001). The duration of continuous positive airway pressure (CPAP) was significantly shorter in patients in the caffeine group (4.1 days) than in the no caffeine group (7.1 days) (p = 0.003). There was a nonsignificant shorter duration of nutritional support in those who required ventilatory support (p = 0.05). Caffeine was well tolerated.
Conclusion:
Caffeine reduced the duration of CPAP and the need for and duration of nutritional support through a direct effect on the digestive system or overall improvement. These results should be confirmed by randomised trials.
More Related Videos
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
COPD: Management Using Bronchodilators and Corticosteroids
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...